World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
48142
World Ranking
4361
National Ranking
2382

Overview

Jerry H. Gurwitz is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Geriatrics and Gerontology.

Their work spans several subfields including:

  • Geriatrics and Gerontology
  • Cardiology and Cardiovascular Medicine
  • Economics and Econometrics
  • General Health Professions
  • Epidemiology

Key topics addressed in their research include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Practices and Patient Outcomes
  • Frailty in Older Adults
  • Atrial Fibrillation Management and Outcomes
  • Geriatric Care and Nursing Homes
  • Medication Adherence and Compliance
  • Chronic Disease Management Strategies

Jerry H. Gurwitz has contributed to numerous recent publications. Some notable papers include:

  • "A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries," 2020, published in New England Journal of Medicine
  • "Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens," 2021, published in The Lancet Healthy Longevity
  • "Age, Multiple Chronic Conditions, and COVID-19: A Literature Review," 2020, published in The Journals of Gerontology Series A
  • "Roadmap to 2030 for Drug Evaluation in Older Adults," 2021, published in Clinical Pharmacology & Therapeutics
  • "The Paradoxical Decline of Geriatric Medicine as a Profession," 2023, published in JAMA

The researcher has frequently collaborated with several co-authors, including:

  • Paula A. Rochon
  • Robert J. Goldberg
  • Kathleen M. Mazor
  • David D. McManus
  • Jane S. Saczynski

Jerry H. Gurwitz's work appears most often in the following publication venues:

  • Journal of the American Geriatrics Society
  • European Geriatric Medicine
  • Journal of General Internal Medicine
  • The American Journal of Medicine
  • JAMA Cardiology

Best Publications

  • Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

    Jerry H. Gurwitz;Terry S. Field;Leslie R. Harrold;Jeffrey M. Rothschild

  • Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

    David J. Graham;Judy A. Staffa;Deborah Shatin;Susan E. Andrade

  • Reduction of bacteriuria and pyuria after ingestion of cranberry juice.

    Jerry Avorn;Mark Monane;Jerry H. Gurwitz;Robert J. Glynn

  • Incidence and preventability of adverse drug events in nursing homes.

    Jerry H. Gurwitz;Terry S. Field;Jerry Avorn;Jerry Avorn;Danny McCormick

  • Temporal trends in cardiogenic shock complicating acute myocardial infarction

    Robert J. Goldberg;Navid A. Samad;Jorge L. Yarzebski;Jerry H. Gurwitz

  • Antipsychotic Drug Use and Mortality in Older Adults with Dementia

    Sudeep S. Gill;Susan E. Bronskill;Sharon-Lise T. Normand;Geoffrey M. Anderson

  • Optimising drug treatment for elderly people: the prescribing cascade

    Paula A Rochon;Jerry H Gurwitz

  • Prescription drug use in pregnancy.

    Susan E. Andrade;Jerry H. Gurwitz;Robert L. Davis;K. Arnold Chan

  • The exclusion of the elderly and women from clinical trials in acute myocardial infarction.

    Jerry H. Gurwitz;Nananda F. Col;Jerry Avorn

  • Inhibitors of Hydroxymethylglutaryl-Coenzyme A Reductase and Risk of Fracture Among Older Women

    K. Arnold Chan;Susan E. Andrade;Myde Boles;Diana S. M. Buist

  • Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction: A Randomized Controlled Trial

    Stephen B. Soumerai;Thomas J. McLAUGHLIN;Jerry H. Gurwitz;Edward Guadagnoli

  • The incidence of adverse drug events in two large academic long-term care facilities

    Jerry H. Gurwitz;Terry S. Field;James Judge;Paula A. Rochon

  • Risk factors for adverse drug events among nursing home residents.

    Terry S. Field;Jerry H. Gurwitz;Jerry Avorn;Danny McCormick

  • Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature

    Becky A. Briesacher;Jerry H. Gurwitz;Stephen B. Soumerai

  • The ambiguous relation between aging and adverse drug reactions.

    Jerry H. Gurwitz;Jerry Avorn

  • A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

    Paula A. Rochon;Jerry H. Gurwitz;Robert W. Simms;Paul R. Fortin

  • Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

    Sudeep S. Gill;Paula A. Rochon;Nathan Herrmann;Philip E. Lee

  • The Effect of Computerized Physician Order Entry with Clinical Decision Support on the Rates of Adverse Drug Events: A Systematic Review

    Jesse I. Wolfstadt;Jerry H. Gurwitz;Terry S. Field;Monica Lee

  • Risk factors for adverse drug events among older adults in the ambulatory setting.

    Terry S. Field;Jerry H. Gurwitz;Leslie R. Harrold;Jeffrey Rothschild

  • The Effects of Initial Drug Choice and Comorbidity on Antihypertensive Therapy Compliance* Results From a Population-Based Study in the Elderly

    Mark Monane;Rhonda L. Bohn;Jerry H. Gurwitz;Robert J. Glynn

Frequent Co-Authors

Robert J. Goldberg
Robert J. Goldberg University of Massachusetts Chan Medical School
Paula A. Rochon
Paula A. Rochon University of Toronto
Jerry Avorn
Jerry Avorn Brigham and Women's Hospital
Joel M. Gore
Joel M. Gore University of Massachusetts Chan Medical School
Stephen B. Soumerai
Stephen B. Soumerai Harvard University
Kathleen M. Mazor
Kathleen M. Mazor University of Massachusetts Chan Medical School
Richard Platt
Richard Platt Harvard University
David J. Magid
David J. Magid University of Colorado Denver
Alan S. Go
Alan S. Go Kaiser Permanente
Robert J. Glynn
Robert J. Glynn Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers doesn't always mean attending traditional medical school. There are a variety of online programs in healthcare that offer flexible, affordable, and reputable pathways to launch or advance your career. Options like nursing and medical billing are popular due to high demand and diverse career opportunities.

Many students consider nursing school online as a practical alternative, thanks to flexible scheduling and lower tuition compared to on-campus options. For those aiming to become nurse practitioners, researching the cheapest online fnp programs helps identify routes to advanced practice with minimal debt.

If you’re interested in healthcare administration, you might ask, how much is medical billing and coding school? These programs offer quick entry into the industry at affordable rates. Meanwhile, experienced nurses looking to achieve the highest credentials should consider the cheapest dnp programs to fully maximize their career potential in advanced roles.

Exploring these online degree options can offer flexible entry points and specialized opportunities within the broader field of healthcare in the USA.

Best Scientists Citing Jerry H. Gurwitz

Trending Scientists